Quantitative phosphoproteomic analysis reveals system-wide signaling pathways downstream of SDF-1/CXCR4 in breast cancer stem cells

Significance Tumor metastasis is the major cause of cancer lethality, whereas the underlying mechanisms are obscure. Breast cancer stem cells (CSCs) are essential for breast cancer relapse and metastasis and stromal cell-derived factor 1 (SDF-1)/chemokine (C-X-C motif) receptor 4 (CXCR4) is a key regulator of tumor dissemination. We report a large-scale quantification of SDF-1/CXCR4–induced phosphoproteome events and identify several previously unidentified phosphoproteins and signaling pathways in breast CSCs. This study provides insights into the understanding of the mechanisms of breast cancer metastasis. Breast cancer is the leading cause of cancer-related mortality in women worldwide, with an estimated 1.7 million new cases and 522,000 deaths around the world in 2012 alone. Cancer stem cells (CSCs) are essential for tumor reoccurrence and metastasis which is the major source of cancer lethality. G protein-coupled receptor chemokine (C-X-C motif) receptor 4 (CXCR4) is critical for tumor metastasis. However, stromal cell-derived factor 1 (SDF-1)/CXCR4–mediated signaling pathways in breast CSCs are largely unknown. Using isotope reductive dimethylation and large-scale MS-based quantitative phosphoproteome analysis, we examined protein phosphorylation induced by SDF-1/CXCR4 signaling in breast CSCs. We quantified more than 11,000 phosphorylation sites in 2,500 phosphoproteins. Of these phosphosites, 87% were statistically unchanged in abundance in response to SDF-1/CXCR4 stimulation. In contrast, 545 phosphosites in 266 phosphoproteins were significantly increased, whereas 113 phosphosites in 74 phosphoproteins were significantly decreased. SDF-1/CXCR4 increases phosphorylation in 60 cell migration- and invasion-related proteins, of them 43 (>70%) phosphoproteins are unrecognized. In addition, SDF-1/CXCR4 upregulates the phosphorylation of 44 previously uncharacterized kinases, 8 phosphatases, and 1 endogenous phosphatase inhibitor. Using computational approaches, we performed system-based analyses examining SDF-1/CXCR4–mediated phosphoproteome, including construction of kinase–substrate network and feedback regulation loops downstream of SDF-1/CXCR4 signaling in breast CSCs. We identified a previously unidentified SDF-1/CXCR4-PKA-MAP2K2-ERK signaling pathway and demonstrated the feedback regulation on MEK, ERK1/2, δ-catenin, and PPP1Cα in SDF-1/CXCR4 signaling in breast CSCs. This study gives a system-wide view of phosphorylation events downstream of SDF-1/CXCR4 signaling in breast CSCs, providing a resource for the study of CSC-targeted cancer therapy.

[1]  R. Seger,et al.  The MAPK cascades: signaling components, nuclear roles and mechanisms of nuclear translocation. , 2011, Biochimica et biophysica acta.

[2]  Tony Pawson,et al.  Comparative Analysis Reveals Conserved Protein Phosphorylation Networks Implicated in Multiple Diseases , 2009, Science Signaling.

[3]  D. Moller,et al.  Regulation and Interaction of pp90rsk Isoforms with Mitogen-activated Protein Kinases* , 1996, The Journal of Biological Chemistry.

[4]  Katsuyuki Kunida,et al.  Processive phosphorylation of ERK MAP kinase in mammalian cells , 2011, Proceedings of the National Academy of Sciences.

[5]  W. Janzen,et al.  High Throughput Screening , 2016, Methods in Molecular Biology.

[6]  A. Ashworth,et al.  Identification of the sites in MAP kinase kinase‐1 phosphorylated by p74raf‐1. , 1994, The EMBO journal.

[7]  R. Steinberg,et al.  Physiological Phosphorylation of Protein Kinase A at Thr-197 Is by a Protein Kinase A Kinase , 1998, Molecular and Cellular Biology.

[8]  M. Walsh,et al.  The myosin phosphatase targeting protein (MYPT) family: a regulated mechanism for achieving substrate specificity of the catalytic subunit of protein phosphatase type 1δ. , 2011, Archives of biochemistry and biophysics.

[9]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[10]  M. Inagaki,et al.  Visualization and function of vimentin phosphorylation by cdc2 kinase during mitosis. , 1994, Journal of Biological Chemistry.

[11]  S. Alemà,et al.  p120 catenin and phosphorylation: Mechanisms and traits of an unresolved issue. , 2007, Biochimica et biophysica acta.

[12]  M. Thelen,et al.  The Chemokine SDF-1/CXCL12 Binds to and Signals through the Orphan Receptor RDC1 in T Lymphocytes* , 2005, Journal of Biological Chemistry.

[13]  T. Grundström,et al.  Calcium regulation of GM-CSF by calmodulin-dependent kinase II phosphorylation of Ets1. , 2002, Molecular biology of the cell.

[14]  R. Lefkowitz,et al.  β-Arrestins and Cell Signaling , 2007 .

[15]  K. Aldape,et al.  FAK phosphorylation by ERK primes ras-induced tyrosine dephosphorylation of FAK mediated by PIN1 and PTP-PEST. , 2009, Molecular cell.

[16]  T. Mcclanahan,et al.  Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.

[17]  Steven P Gygi,et al.  The SCX/IMAC enrichment approach for global phosphorylation analysis by mass spectrometry , 2008, Nature Protocols.

[18]  R. Hendrickson,et al.  Identification of Direct Target Engagement Biomarkers for Kinase-Targeted Therapeutics , 2011, PloS one.

[19]  P. Sandy,et al.  Glycogen synthase kinase-3 beta regulates NF-kappa B1/p105 stability. , 2003, The Journal of biological chemistry.

[20]  Eric S. Lander,et al.  Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening , 2009, Cell.

[21]  D. Brautigan,et al.  Phosphorylation and functions of inhibitor-2 family of proteins. , 2007, Biochemistry.

[22]  Kouji Matsushima,et al.  The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract , 1998, Nature.

[23]  A. Bossler,et al.  Impaired PTPN13 phosphatase activity in spontaneous or HPV-induced squamous cell carcinomas potentiates oncogene signaling via the MAP kinase pathway , 2009, Oncogene.

[24]  John D. Scott,et al.  AKAP signalling complexes: focal points in space and time , 2004, Nature Reviews Molecular Cell Biology.

[25]  Wendell A. Lim,et al.  Scaffold Proteins: Hubs for Controlling the Flow of Cellular Information , 2011, Science.

[26]  Yi Tang,et al.  In Vivo Activation of Protein Kinase A in Schizosaccharomyces pombe Requires Threonine Phosphorylation at Its Activation Loop and Is Dependent on PDK1 , 2004, Genetics.

[27]  P. Dorrestein,et al.  Elucidating the CXCL12/CXCR4 Signaling Network in Chronic Lymphocytic Leukemia through Phosphoproteomics Analysis , 2010, PloS one.

[28]  M. Mann,et al.  Global, In Vivo, and Site-Specific Phosphorylation Dynamics in Signaling Networks , 2006, Cell.

[29]  J. Settleman,et al.  p120-Catenin and p190RhoGAP Regulate Cell-Cell Adhesion by Coordinating Antagonism between Rac and Rho , 2006, Cell.

[30]  Y. She,et al.  Quantification of protein isoforms in mesenchymal stem cells by reductive dimethylation of lysines in intact proteins , 2012, Proteomics.

[31]  Beverly A. Teicher,et al.  CXCL12 (SDF-1)/CXCR4 Pathway in Cancer , 2010, Clinical Cancer Research.

[32]  T. Mikalsen,et al.  Activation of MK5/PRAK by the atypical MAP kinase ERK3 defines a novel signal transduction pathway , 2004, The EMBO journal.

[33]  P. Bork,et al.  Systematic Discovery of In Vivo Phosphorylation Networks , 2007, Cell.

[34]  P. Sandy,et al.  Glycogen Synthase Kinase-3β Regulates NF-κB1/p105 Stability* , 2003, Journal of Biological Chemistry.

[35]  R. Lefkowitz,et al.  Beta-arrestins and cell signaling. , 2007, Annual review of physiology.